CTMI Cti Molecular Imaging - Common Stock (MM)

CTI Molecular Imaging, Inc. Cancels Second Quarter Earnings Call KNOXVILLE, Tenn., May 3 /PRNewswire-FirstCall/ -- CTI Molecular Imaging, Inc. (NASDAQ:CTMI), a leading provider of positron emission tomography (PET) equipment, molecular probes and services, announces that it has cancelled the fiscal second quarter earnings conference call scheduled for May 5, 2005. About CTI Molecular Imaging: CTI Molecular Imaging, Inc. is a leading supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, neurological disorders and cardiac disease. Additional information is available at: http://www.ctimi.com/ . DATASOURCE: CTI Molecular Imaging, Inc. CONTACT: David N. Gill of CTI Molecular Imaging, Inc., +1-865-218-2000 Web site: http://www.ctimi.com/

Copyright